Understanding immune responses to develop vaccines and treatments for infectious diseases
NIH Tetramer Core Facility
This study is all about helping scientists learn more about how our immune system fights infections and diseases, so they can create better vaccines and treatments that could eventually help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10812213 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses to infectious and immune-mediated diseases. It involves the synthesis and distribution of Major Histocompatibility Complex (MHC) tetramer reagents, which are crucial for studying how the immune system recognizes pathogens. By providing these resources to researchers worldwide, the project aims to facilitate the development of new vaccines and therapeutic agents. Patients may benefit indirectly through advancements in treatments that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases or those at risk of such conditions.
Not a fit: Patients with non-infectious diseases or conditions unrelated to immune responses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapies for infectious diseases.
How similar studies have performed: Previous research utilizing MHC tetramer technology has shown promise in understanding immune responses and developing vaccines, indicating a strong potential for success in this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.